Tema Oncology ETF (CANC) Short Interest Ratio & Short Volume

Short interest is the volume of Tema Oncology ETF shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 800 shares of CANC short. Learn More on Tema Oncology ETF's current short interest.

Tema Oncology ETF saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 800 shares, a decline of 20.0% from the previous total of 1,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Tema Oncology ETF: Tradr 2X Short Innovation Daily ETF (12.03%), Global X Telemedicine & Digital Health ETF (0.05%), Procure Space ETF (4.43%), AOT Growth & Innovation ETF (0.01%), Roundhill GLP-1 & Weight Loss ETF (4.15%), Spear Alpha ETF (0.24%), First Trust Dow Jones International Internet ETF (2.86%), Democratic Large Cap Core ETF (1.10%), Global X Blockchain & Bitcoin Strategy ETF (4.05%), Fidelity Disruptive Medicine ETF (0.49%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks.

Short selling CANC is an investing strategy that aims to generate trading profit from Tema Oncology ETF as its price is falling. CANC shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Tema Oncology ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CANC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CANC, twice per month. The most recent reporting period available is November, 15 2024.